GeneDx Holdings
67 hedge funds and large institutions have $360M invested in GeneDx Holdings in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 18 closing their positions.
693% more call options, than puts
Call options by funds: $17.1M | Put options by funds: $2.15M
155% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 11
0% more funds holding
Funds holding: 67 → 67 (0)
0% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 18
0.09% less ownership
Funds ownership: 1.9% → 1.81% (-0.09%)
11% less capital invested
Capital invested by funds: $403M → $360M (-$42.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$11.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.14M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.86M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.58M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
+$3.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHCM
Sachem Head Capital Management
New York
|
-$22.3M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
-$8.93M |
| 3 |
Blackstone Inc
New York
|
-$8.03M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$5.4M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$3.8M |
WGS Hedge Fund Activity: Q2 2021 in Review
67 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2021, worth a combined $360M — down 11% from $403M a quarter earlier.
Fund positioning in WGS was balanced in Q2 2021: 18 funds opened new positions, 18 closed out, 28 added to existing stakes and 11 trimmed.
The largest buyer was SB Management, adding an estimated $11.1M. The largest seller was Sachem Head Capital Management, exiting entirely with an estimated $22.3M sold.
- 67 institutional investors held GeneDx Holdings (WGS) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $360M of GeneDx Holdings stock for Q2 2021, down 11% quarter-over-quarter.
- 18 funds opened new GeneDx Holdings positions in Q2 2021 and 18 closed out, a net change of 0 holders.
- The largest GeneDx Holdings buyer in Q2 2021 was SB Management, an estimated $11.1M added.
- The largest GeneDx Holdings seller in Q2 2021 was Sachem Head Capital Management, an estimated $22.3M sold.
Based on aggregated 13F filings for Q2 2021.